Consolidated Condensed Statements of Cash Flows
|
Three Months Ended |
||
(In Millions; Unaudited) |
Apr 1, 2023 |
|
Apr 2, 2022 |
|
|
|
|
Cash and cash equivalents, beginning of period |
$ 11,144 |
|
$ 4,827 |
Cash flows provided by (used for) operating activities: |
|
|
|
Net income (loss) |
(2,768) |
|
8,113 |
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
Depreciation |
1,901 |
|
2,847 |
Share-based compensation |
739 |
|
707 |
Restructuring and other charges |
55 |
|
17 |
Amortization of intangibles |
465 |
|
501 |
(Gains) losses on equity investments, net |
(167) |
|
(4,325) |
(Gains) losses on divestitures |
— |
|
(1,121) |
Changes in assets and liabilities: |
|
|
|
Accounts receivable |
286 |
|
2,384 |
Inventories |
231 |
|
(1,147) |
Accounts payable |
(771) |
|
(128) |
Accrued compensation and benefits |
(1,560) |
|
(1,884) |
Income taxes |
1,344 |
|
1,219 |
Other assets and liabilities |
(1,540) |
|
(1,292) |
Total adjustments |
983 |
|
(2,222) |
Net cash provided by (used for) operating activities |
(1,785) |
|
5,891 |
Cash flows provided by (used for) investing activities: |
|
|
|
Additions to property, plant and equipment |
(7,413) |
|
(4,604) |
Purchases of short-term investments |
(16,132) |
|
(19,091) |
Maturities and sales of short-term investments |
14,173 |
|
10,490 |
Sales of equity investments |
116 |
|
4,682 |
Proceeds from divestitures |
— |
|
6,544 |
Other investing |
735 |
|
(660) |
Net cash used for investing activities |
(8,521) |
|
(2,639) |
Cash flows provided by (used for) financing activities: |
|
|
|
Repayment of commercial paper |
(2,930) |
|
— |
Payments on finance leases |
(15) |
|
(299) |
Partner contributions |
449 |
|
— |
Issuance of long-term debt, net of issuance costs |
10,968 |
|
— |
Proceeds from sales of common stock through employee equity incentive plans |
659 |
|
589 |
Payment of dividends to stockholders |
(1,512) |
|
(1,487) |
Other financing |
(225) |
|
(667) |
Net cash provided by (used for) financing activities |
7,394 |
|
(1,864) |
Net increase (decrease) in cash and cash equivalents |
(2,912) |
|
1,388 |
Cash and cash equivalents, end of period |
$ 8,232 |
|
$ 6,215 |